Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway
Article in Biochemical Pharmacology (March 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Rare de novo gain-of-function missense variants in DOT1L are associated with developmental delay and congenital anomalies
Article in American Journal of Human Genetics (October 2023)
Hydroxysafflor yellow A inhibits the hyperactivation of rat platelets by regulating the miR-9a-5p/SRC axis
Article in Archives of Biochemistry and Biophysics (September 2023)